GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes

In this episode, pharmacists Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM, and Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP, discuss the use of GLP-1 receptor agonists in patients with type 2 diabetes and provide answers to commonly asked questions. Listen to their conversation about the differences between short-acting vs long-acting agents; the benefits of use in combination with other medications, such as SGLT2 inhibitors, DPP-4 inhibitors, and metformin; their benefits in heart failure; and their role in the updated consensus statement from the American Diabetes Association/European Association for the Study of Diabetes. 

Presenters:

Kristi W. Kelley, PharmD, FCCP, BCPS, BCACP, CDCES, BC-ADM
Clinical Professor
Department of Pharmacy Practice
Auburn University Harrison College of Pharmacy
Clinical Pharmacist
Baptist Health Foundation Center for Medical and Surgical Care
Princeton Baptist Medical Center/Brookwood Baptist Health
Birmingham, Alabama

Christie Schumacher, PharmD, BCPS, BCACP, BCCP, BC-ADM, CDCES, FCCP
Professor
Department of Pharmacy Practice
Midwestern University
College of Pharmacy
Downers Grove, Illinois
Clinical Pharmacist
Advocate Medical Group
Chicago, Illinois

Content based on an online CE program supported by an educational grant from Novo Nordisk, Inc.

Link to full program: 
https://bit.ly/3Un1xQi

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.